Overuse of anticoagulants raises dementia risk in AF patients

Long-term overtreatment with anticoagulants combined with antiplatelet therapy to prevent stroke could increase the risk of dementia in patients with AF, researchers have found.

Dementia: risk from overuse of anticoagulants (Photo: JH Lancy)
Dementia: risk from overuse of anticoagulants (Photo: JH Lancy)

US researchers found that long-term use of warfarin, if not well controlled, can significantly increase a patient’s bleeding risk and produce micro-bleeds which can, over time, raise the risk of dementia.

The research, presented at the American Heart Association Scientific Sessions 2014, found that patients with abnormally slow blood clotting times, considered a sign of receiving too much medication, on a quarter or more of their monitoring tests were more than twice as likely to be diagnosed with dementia.

The increase is higher than found in previous studies by the same team of researchers, which looked at patients treated only with warfarin.

The researchers suggested that patients taking warfarin and an antiplatelet drug such as aspirin should ask their doctor if both drugs were necessary.

16,000 strokes prevented

Earlier this month, NHS Improving Quality suggested that 16,000 strokes could have been prevented in England if eligible AF patients were treated with anticoagulants.

It concluded that 3,200 of these strokes would have been fatal, and that if all eligible patients were given warfarin it would have saved the NHS £124m a year.

Last month, clinical geneticist Professor Sir John Burn told the RCGP annual conference that testing patients for genetic sensitivity to warfarin could improve outcomes and save money.

Professor Burn, from Newcastle University, said the required type of genetic testing could be done for £20 in 20 minutes, and he said his team had begun to trial point-of-care tasting and genotype-led dosage adjustment of warfarin in Newcastle.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Vaccination tracker

UK COVID-19 vaccination programme tracker

GPs across the UK have led the largest-ever NHS vaccination programme in response...

RCGP chair Professor Martin Marshall

Hand PCNs control of primary care infrastructure funding, says RCGP

CCG funding for primary care infrastructure should be handed to PCNs when the bodies...

Professor Martin Marshall and Talking General Practice logo

Podcast: RCGP chair Professor Martin Marshall

Talking General Practice speaks to RCGP chair Professor Martin Marshall.

Dr Chaand Nagpaul

In-house review not enough to stop 'unjust' GMC referrals, warns BMA

Doctors' leaders have repeated calls for a full independent review of the GMC referral...


How widespread is long COVID in the UK?

Millions of people in the UK are living with long COVID. GPonline looks at the data...

COVID-19 vaccination sign

GP contract for autumn COVID-19 booster campaign due shortly

GP practices in England will be invited shortly to sign up for the COVID-19 autumn...